Cipla

Latest News

Cipla Receives Approval for Afrezza Insulin, Sales Begin in India

Indian pharmaceutical company Cipla has received approval from the Central Drugs Standard Control Organization (CDSCO) to distribute and market Afrezza,…

Read More »
Tell Me Doctor

Favipiravir a broad spectrum inhibitor of viral RNA polymerase emerges as one of most promising drugs for COVID19

CSIR identifies top 25 drugs/drug candidates for repurposing CSIR-IICT, based in Hyderabad, develops a convenient and cost effective synthetic process…

Read More »
Back to top button